Your browser doesn't support javascript.
loading
Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID-19 patients.
Kalantari, Saeed; Fard, Soheil R; Maleki, Donya; Taher, Mahshid T; Yassin, Zeynab; Alimohamadi, Yousef; Minaeian, Sara.
Afiliación
  • Kalantari S; Antimicrobial Resistance Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran.
  • Fard SR; Department of Infectious Diseases, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Maleki D; Antimicrobial Resistance Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran.
  • Taher MT; Antimicrobial Resistance Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran.
  • Yassin Z; Department of Infectious Diseases, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Alimohamadi Y; Antimicrobial Resistance Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran.
  • Minaeian S; Department of Infectious Diseases, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
J Med Virol ; 93(12): 6557-6565, 2021 12.
Article en En | MEDLINE | ID: mdl-34255369

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Oxazinas / Piperazinas / Piridonas / Ritonavir / Lopinavir / Sulfato de Atazanavir / Tratamiento Farmacológico de COVID-19 / Compuestos Heterocíclicos con 3 Anillos / Hidroxicloroquina Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Med Virol Año: 2021 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Oxazinas / Piperazinas / Piridonas / Ritonavir / Lopinavir / Sulfato de Atazanavir / Tratamiento Farmacológico de COVID-19 / Compuestos Heterocíclicos con 3 Anillos / Hidroxicloroquina Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Med Virol Año: 2021 Tipo del documento: Article País de afiliación: Irán